475 related articles for article (PubMed ID: 25090589)
1. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer.
Nejati-Koshki K; Mesgari M; Ebrahimi E; Abbasalizadeh F; Fekri Aval S; Khandaghi AA; Abasi M; Akbarzadeh A
J Microencapsul; 2014; 31(8):815-23. PubMed ID: 25090589
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.
Akbarzadeh A; Mikaeili H; Zarghami N; Mohammad R; Barkhordari A; Davaran S
Int J Nanomedicine; 2012; 7():511-26. PubMed ID: 22334781
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells.
Sadeghzadeh H; Pilehvar-Soltanahmadi Y; Akbarzadeh A; Dariushnejad H; Sanjarian F; Zarghami N
Anticancer Agents Med Chem; 2017; 17(10):1363-1373. PubMed ID: 28270067
[TBL] [Abstract][Full Text] [Related]
5. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
[TBL] [Abstract][Full Text] [Related]
6. Preparation and Evaluation of Chrysin Encapsulated in PLGA- PEG Nanoparticles in the T47-D Breast Cancer Cell Line.
Mohammadinejad S; Akbarzadeh A; Rahmati-Yamchi M; Hatam S; Kachalaki S; Zohreh S; Zarghami N
Asian Pac J Cancer Prev; 2015; 16(9):3753-8. PubMed ID: 25987033
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
9. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
12. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
13. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
14. Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer.
Ebrahimi E; Akbarzadeh A; Abbasi E; Khandaghi AA; Abasalizadeh F; Davaran S
Artif Cells Nanomed Biotechnol; 2016; 44(1):290-7. PubMed ID: 25111052
[TBL] [Abstract][Full Text] [Related]
15. A simple and general method for preparing antibody-PEG-PLGA sub-micron particles using electrospray technique: an in vitro study of targeted delivery of cisplatin to ovarian cancer cells.
Bai MY; Liu SZ
Colloids Surf B Biointerfaces; 2014 May; 117():346-53. PubMed ID: 24681046
[TBL] [Abstract][Full Text] [Related]
16. Characterisation, cytotoxicity and apoptosis studies of methotrexate-loaded PLGA and PLGA-PEG nanoparticles.
Afshari M; Derakhshandeh K; Hosseinzadeh L
J Microencapsul; 2014; 31(3):239-45. PubMed ID: 24124881
[TBL] [Abstract][Full Text] [Related]
17. In vitro study and characterization of doxorubicin-loaded magnetic nanoparticles modified with biodegradable copolymers.
Ebrahimi E; Khandaghi AA; Valipour F; Babaie S; Asghari F; Motaali S; Abbasi E; Akbarzadeh A; Davaran S
Artif Cells Nanomed Biotechnol; 2016; 44(2):550-8. PubMed ID: 25345419
[TBL] [Abstract][Full Text] [Related]
18. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
19. Improved efficacy of cisplatin in combination with a nano-formulation of pentacyclic triterpenediol.
Alam N; Qayum A; Kumar A; Khare V; Sharma PR; Andotra SS; Singh SK; Koul S; Gupta PN
Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():109-116. PubMed ID: 27524002
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
